Related Experiment Video
Updated: Aug 11, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Successful treatment of non-Hodgkin's lymphoma in a patient with common variable immunodeficiency
T Ohnoshi1, K Hayashi, S Tagawa
1Second Department of Medicine, Okayama University Medical School, Japan.
Insights
Common variable immunodeficiency (CVID) patients can develop rectal non-Hodgkin's lymphoma (NHL). Successful treatment involved chemotherapy and immunoglobulin therapy, leading to long-term remission.
Area of Science:
- Immunology
- Oncology
- Gastroenterology
Background:
- Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by low immunoglobulin levels and impaired B-cell function.
- Patients with CVID have an increased risk of developing certain malignancies, including lymphomas.
- Rectal non-Hodgkin's lymphoma (NHL) is a rare presentation, particularly in the context of immunodeficiency.
Observation:
- A 22-year-old male with a history of CVID diagnosed at age 7 presented with rectal NHL.
- The patient had stage IE disease confined to the rectum.
- Initial treatment with radiation therapy resulted in a relapse in the paraaortic lymph nodes.
Findings:
- The patient achieved successful remission of rectal NHL following CHOP-Bleo chemotherapy.
- Supplementation with immunoglobulin preparations was crucial in managing the patient's underlying immunodeficiency.
- The patient remained disease-free from NHL and infectious complications for over 30 months post-treatment.
Implications:
- This case highlights the importance of vigilant monitoring for malignancies in CVID patients.
- Combined modality treatment, including chemotherapy and immunoglobulin replacement, can be effective in managing NHL in immunocompromised individuals.
- Further research is warranted to understand the specific mechanisms linking CVID and lymphomagenesis.
Abstract:
A case of common variable immunodeficiency (CVID) who developed non-Hodgkin's lymphoma (NHL) of the rectum is reported. A 22-year-old male student in whom CVID was diagnosed at 7 years of age was referred to our department for the treatment of rectal NHL. The patient had stage IE disease confined to the rectum after clinical diagnostic procedures. He was initially treated with radiation therapy alone, but a relapse soon occurred in the paraaortic lymph nodes. He was successfully treated with CHOP-Bleo chemotherapy and supplementation with immunoglobulin preparations. He has since remained free of NHL and infectious complications for over 30 months despite his persistent immunodeficiency.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

